← Back to Search

Other

MyTAP oral appliance plus mouth shield for Atrial Fibrillation

N/A
Waitlist Available
Led By Emet Schneiderman, PhD
Research Sponsored by Texas A&M University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights

Study Summary

This study is evaluating whether a mouthguard may help reduce the number of atrial fibrillation events for individuals with atrial fibrillation.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
AF incidence
Periodontal conditions
Secondary outcome measures
Apnea hypopnea index after 1 month (T2) compared with T0-1
Epworth Sleepiness Scale (ESS); Score ≥10 is sleepy, ≥ 18 is very sleepy.
Heart rate variability analysis after 1 month compared with baseline (T0)
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: MyTAP oral appliance plus mouth shieldExperimental Treatment1 Intervention
MyTAP plus mouth shield
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MyTAP oral appliance plus mouth shield
2018
N/A
~50

Find a Location

Who is running the clinical trial?

Texas A&M UniversityLead Sponsor
140 Previous Clinical Trials
24,086 Total Patients Enrolled
Emet Schneiderman, PhDPrincipal InvestigatorTAMHSC
2 Previous Clinical Trials
151 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~3 spots leftby Apr 2025